Navigation Links
Diabetes Patients with High Triglycerides and Low HDL Cholesterol Get the Most Benefit From Fenofibrate Treatment: New Data From the FIELD Study
Date:2/26/2009

te, argue for consideration of fenofibrate in the clinical management of patients with type 2 diabetes and marked atherogenic dyslipidemia.

Professor Richard O'Brien, a diabetes specialist and Clinical Dean of Medicine at the University of Melbourne, Austin and Northern Clinical Schools, added:

These findings on macrovascular disease build on earlier results of the FIELD trial showing clear benefits for patients with microvascular complications. Fenofibrate reduces the need for laser treatment in patients with diabetic disease in the small vessels of the eyes. It also reduces the risk of amputations resulting from disease in the small vessels of the limbs.

FIELD (5), a large international multicentre trial in which 9795 patients were followed up over 5 years, was coordinated at the NHMRC Clinical Trials Centre at the University of Sydney. Professor Anthony Keech, Professor of Medicine, Cardiology and Epidemiology and Deputy Director of the trials centre, is chair of the trial.

Notes for Editors

What is the FIELD study?

The FIELD trial was a randomised, double-blind, placebo-controlled study in 9795 patients with type 2 diabetes. The study evaluated whether treatment with fenofibrate (200 mg/day) for a median of 5 years could reduce macrovascular and microvascular complications of type 2 diabetes. Macrovascular study endpoints were major coronary events (primary) and total cardiovascular events (secondary). Microvascular endpoints were laser treatment for diabetic retinopathy, progression of albuminuria and non-traumatic lower-extremity amputation.

What were the key macrovascular findings in the FIELD study?

After a mean of 5 years treatment, fenofibrate was associated with a non-significant 11% reduction in the primary endpoint. However, there was a significant reduction in the secondary endpoint (reduction b
'/>"/>

SOURCE Solvay
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. February 2009 Mayo Clinic Womens HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus
2. MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
3. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
4. Epidemics of Both Type 1 Diabetes (Insulin Dependent) and Type 2 Diabetes (Obesity Related) Are Linked to Immunization
5. Overweight Siblings of Children With Type 2 Diabetes Likely to Have Abnormal Blood Sugar Levels
6. Patient Recruitment Begins in India for Phase 3 Diabetes Trial
7. Opportunities to Highlight Type 1 Diabetes in November
8. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
9. FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
10. TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program
11. Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... -- The American Association for Homecare (AAHomecare), along with a ... announced today the filing of a lawsuit in ... asking that the scheduled July 1 expansion of the Medicare ... stopped because of serious licensing irregularities. The lawsuit ... Secretary Kathleen Sebelius as the defendant. HHS oversees ...
(Date:6/19/2013)... 19, 2013 Ellen MacArthur ... kommande tre åren kommer att vara en partner ... cirkulär ekonomi. Efter stiftelsens framgångsrika partnerskap ... Grid, kommer Philips att ansluta sig som partner ... i sin egen verksamhet och stödja stiftelsens arbete ...
(Date:6/19/2013)... , June 19, 2013  Finesse Solutions, Inc, ... life sciences process applications, announced the launch of ... upstream cell culture and fermentation.  The 3L glass ... family of Finesse bioreactors and are designed to ... They are fully compatible with all Finesse G3Lab ...
Breaking Medicine Technology:AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 2Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2
... 11, 2011 MedQuist Holdings Inc. (Nasdaq: ... of integrated clinical documentation solutions for the U.S. healthcare ... public offering of shares of its common stock.  The ... NASDAQ Global Market under the ticker symbol MEDH. ...
... Feb. 11, 2011 Vitalitec International, ... of the ENCLOSE II Anastomosis Assist Device from Novare ... was developed by Thomas Fogarty, MD, and is designed ... Bypass Procedures. Vitalitec International, Inc. is a ...
Cached Medicine Technology:MedQuist Holdings Inc. Announces Closing of Its Initial U.S. Public Offering and Acquisition of Additional Shares of MedQuist Inc. 2MedQuist Holdings Inc. Announces Closing of Its Initial U.S. Public Offering and Acquisition of Additional Shares of MedQuist Inc. 3
(Date:6/19/2013)... Philadelphia, Pa. (June 19, 2013) The results of ... issue of Neurosurgery , official journal of the ... is published by Lippincott Williams & Wilkins , ... One study indicates that continuous "machine learning" using artificial ... survival in patients with advanced brain cancers. Another study ...
(Date:6/19/2013)... In early April, senior leaders from medical, law ... to discuss one question: how can first responders improve ... The preliminary results of this discussion are now available ... Hartford Consensus ," a concept paper published in the ... Trauma and Acute Care Surgery , official publication ...
(Date:6/19/2013)... system for repairing damage to the genetic material DNA ... may seem, those compounds are sparking optimism as potential ... mutation in BRCA, a gene that made headlines when ... compounds, termed PARP inhibitors, are the topic of the ... & Engineering News . C&EN is the weekly news ...
(Date:6/19/2013)... Ariz. (PRWEB) June 19, 2013 PREFERRED ... WellCare of Arizona to offer a new ... Maricopa, Pima, La Paz, Yavapai and Mohave, Arizona counties. ... Mohave counties were effective January 1, 2013 and Maricopa ... 2014. , WellCare, Inc., the parent company of WellCare ...
(Date:6/19/2013)... Kansas City will host its first Ciclovia event ... . A section of Main Street in the midtown area will ... the event. The Main Street Corridor Development and ... Kansas City join the ranks of dozens of cities across the ... foster community vibrancy and active lifestyles. , “Ciclovia is the perfect ...
Breaking Medicine News(10 mins):Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3Health News:Hartford consensus aims to improve survival after mass shootings 2Health News:PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3
... ... , ... 24, 2010 -- At just over 18 pounds and with a sound level of only ... lighter and quieter than its battery-operated competitors. Powered by a lithium ion battery with 30 ...
... halt, expert says , TUESDAY, March 23 (HealthDay News) ... trials that are stopped early due to encouraging results, ... of 91 truncated trials with 424 comparable full-length trials, ... in particular, smaller studies -- reported exaggerated or misleading ...
... Walking, biking, dancing can all help normal-weight women as they ... An hour a day of moderate-intensity exercise will prevent weight ... a new study. , ",Moderate intensity, means brisk walking, casual ... Lee, lead author of the study, which is published in ...
... , BOSTON , March 23 ... current ESPN analyst Tedy Bruschi ... Trustees of Partners Continuing Care, the non-acute division of ... Partners Home Care, Partners Continuing Care offers the full ...
... America today hailed the "Patient Protection and Affordable Care Act" signed by the President today. The legislation will greatly expand access to mental health care ... ... , , ... ...
... , March 23 The Alzheimer,s Foundation of America issued the following statement on the health reform legislation that was signed into law today by President Obama:   , ... , ... ... ...
Cached Medicine News:Health News:Advance Introduces the Adgility™ XPB Battery Backpack Vacuum – the Lightest in the Industry, 2Health News:Abbreviated Trials Yield Misleading Results: Study 2Health News:Being Active an Hour a Day Puts Brakes on Weight Gain 2Health News:Being Active an Hour a Day Puts Brakes on Weight Gain 3Health News:Tedy Bruschi Joins the Board of Trustees for Partners Continuing Care and Spaulding Rehabilitation Network 2Health News:Tedy Bruschi Joins the Board of Trustees for Partners Continuing Care and Spaulding Rehabilitation Network 3Health News:Mental Health America Hails Enactment of Historic Health Care Reform Bill 2Health News:Mental Health America Hails Enactment of Historic Health Care Reform Bill 3Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 2Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 3Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: